The Foundational Concept: Mitochondria are ancient bacterial endosymbionts when their DNA escapes normal compartments, the immune system recognizes it as foreign invasion, triggering inflammatory destruction.

The Mechanism:

Initial Insult: Aging, toxins, or genetic mutations impair mitochondrial quality control. Damaged mitochondria produce excessive ROS, oxidizing lipids, proteins, and critically mtDNA itself.

Permeability Transition: Oxidized mtDNA fragments, combined with membrane potential loss, open mitochondrial permeability transition pores. The outer membrane ruptures.

Cytosol Invasion: Oxidized mtDNA fragments (containing unmethylated CpG motifs resembling bacterial DNA) flood into cytosol a compartment normally DNA-free.

cGAS Detection: Cytosolic DNA sensor cGAS binds these fragments, catalyzing cGAMP synthesis. cGAMP activates STING on ER membranes.

Inflammatory Cascade: STING traffics to Golgi, recruiting TBK1 and IRF3. IRF3 translocates to nucleus, driving Type I interferon transcription. Simultaneously, NF-��B activation produces IL-1��, TNF��.

Bystander Damage: These inflammatory cytokines activate microglia, damage synapses, and recruit cytotoxic T-cells. Neurons with mtDNA release become tagged for immune destruction.

The PD Connection:

PINK1/Parkin mutations impair mitophagy, allowing mtDNA release

PD patients show elevated cell-free mtDNA in CSF

STING knockout rescues dopamine neurons in mouse models

Therapeutic Implications:

cGAS inhibitors preventing cytosolic DNA detection

STING antagonists blocking downstream inflammation

Mitophagy enhancers (urolithin A) clearing damaged mitochondria before rupture

mtDNA oxidation preventatives (MitoQ) reducing initial damage

This reframes neuroinflammation as misguided antimicrobial response immune system attacking neurons for harboring bacterial DNA.